INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • March 2nd, 2017 • Sacks Michael Ivan • Pharmaceutical preparations • New York
THIS INVESTOR RIGHTS AGREEMENT (this “Agreement”), is made as of the 27th day of February, 2017, by and among ULURU Inc., a Nevada corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
BACKSTOP AGREEMENTBackstop Agreement • March 2nd, 2017 • Sacks Michael Ivan • Pharmaceutical preparations • New York
This BACKSTOP AGREEMENT (this “Agreement”) is entered into as of February 27, 2017 (the “Effective Date”) by and between ULURU INC., a Nevada corporation (the “Company”), Bradley J. Sacks (“Buyer”) and Velocitas Partners LLC (“Velocitas”).
VOTING AGREEMENTVoting Agreement • March 2nd, 2017 • Sacks Michael Ivan • Pharmaceutical preparations • New York
THIS VOTING AGREEMENT (this “Agreement”), is made and entered into as of this 27th day of February, 2017, by and among ULURU, Inc., a Nevada corporation (the “Company”), each holder of the Company’s Series B Convertible Preferred Stock, $0.001 par value per share (the “Series B Preferred Stock”) listed on Schedule A (together with any subsequent transferees, who become parties hereto as “Investors” pursuant to Subsection 5.1, the “Investors”), and those certain stockholders of the Company listed on Schedule B (the “Key Holders,” and together collectively with the Investors, the “Stockholders”).
